In a bid to win back investor confidence, Illumina on Tuesday unveiled a three-year growth plan focused on easier DNA sequencing and improved data analysis for customers.
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
Britain’s health regulator said on Wednesday it has approved Japan-based Astellas Pharma’s therapy to treat a type of gastric cancer.
The company announced it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test Galleri, sending its shares up more than 11% in extended trading.
Danish biotech firm Bavarian Nordic said on Tuesday it will donate 40,000 doses of its mpox vaccine to Africa’s top public health body, after the body declared an emergency.
The ACE Awards will be presented on September 24, in conjunction with the HBA’s 25th Annual Conference in Toronto.